Please RT: the registration for the next EuSARC conference in 2024 is open!
https://t.co/T9ngyCcf0i
We look forward to many attendees and great science at the French Atlantic coast!
1/4 Our @biorxivpreprint, 'Origin of Ewing Sarcoma by Embryonic Reprogramming of Neural Crest to Mesoderm' is now available on bioRxiv! In this study, we explore the enigmatic origin of Ewing sarcoma using our zebrafish genetic cancer models. We revealed that neural crest cells can uniquely tolerate EWSR1::FLI1 expression, leading to tumor formation in vivo. A big thanks to our collaborators @clairearataphd and @CrumpLab for this adventurous journey! #NeuralCrest #cancer #EwingSarcoma #zebrafish @amatrudalab @ChildrensLA@biorxiv_cancer👉https://t.co/h0QP0FgX5n
Dear colleagues and friends, as I am sure all of you know, my mentor, colleague, and friend Dr. Chris Fletcher passed away last month. Several of his friends are initiating a fundraising activity through the USCAP Foundation to support an annual award in his name at the USCAP meeting to honor Dr. Fletcher's many outstanding qualities, including excellence in surgical pathology, education, mentorship, leadership, and advocacy. Please consider donating to this fund, as well as passing this on to your colleagues. Thank you so much for your consideration.
@BWHPath@TheUSCAP
https://t.co/6oLVupZTBk
Come and work with us as our new Database Officer! 🎉
The primary purpose of the role is to manage all financial and non-financial donor and fundraiser data between Access CRM and our data providers to meet the charity needs.
To view the job pack, visit: https://t.co/9HUYs2LBqm
3D Printing Tech Can Improve Surgical Outcomes in Retroperitoneal Sarcoma. Patients in the 3D printing group had shorter surgical times, less intraoperative blood loss, shorter hospital stays, and fewer postoperative complications.
https://t.co/Xdggh8PX7j
Check out our latest manuscript describing a potent bicistronic CAR (BiCisCAR) targeting both FGFR4 and CD276 for treating @Rhabdomyosarco https://t.co/ppN3xY2PFI @theNCI @NCIResearchCtr
Super-enhancer-driven CACNA2D2 is an EWSR1::WT1 signature gene encoding a diagnostic marker for desmoplastic small round cell tumor (DSRCT) https://t.co/Lx0EM5PTYG #bioRxiv
Could not agree more! What a wonderful meeting #Eusarc2024 - Good science, good food, good friends, good new collaborations! Thanks to @eu_sarc for organising it and @BCRT for travel grants!
Delighted to have taken part in this year's @eu_sarc . I'd like to thank the scientific committee for awarding me the prize for the best flash talk. What a great way to round off my 6 years at the laboratory before heading off to new adventures in Heidelberg 🇩🇪
#EuSARC@BCRT
We are delighted to represent the primary bone cancer community at the @eu_sarc meeting in France.
With 120 participants, the conference hosts bone sarcoma researchers and clinicians, offering an environment where they can consolidate collaborations to accelerate progress 📈
🔥🔥🔥Neuron-type specific aging-rate reveals age decelerating interventions preventing neurodegeneration. 🧠🧠🧠Read here our latest super exciting #preprint on @researchsquare Congrats to @Meyer_DH and @CGallrein
https://t.co/e4WMFCUJa9
Our new paper "Proteomic features of soft tissue sarcomas in adolescents and young adults (AYA)" is out in @CommsMedicine!
https://t.co/P3T8F6YnHy
We analyse the proteomic profiles of AYA #sarcomas and compared them with those from older patients.
What did we find out? A 🧵1/6